Press Releases
New product to be featured in interactive innovation zones within company booth 3755 during SupplySide West tradeshow
11/01/2022
WILMINGTON, Del., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced the United States Food and Drug Administration (FDA) Center for Drug Evaluation and Research Office of New Drugs has accepted Ashland Viatel ™ bioresorbable mPEG-PDLLA pharmaceutical excipient in the review
10/26/2022
WILMINGTON, Del., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its fourth-quarter earnings release at approximately 5 p.m. ET on Monday, November 7, 2022. The company’s live webcast with securities analysts will include an executive summary and detailed
Company charts significant progress across all three pillars, demonstrating its transformation strategy, enhanced innovation portfolio and multi-regional business focus while delivering on emissions reduction, community engagement, environment and anti-corruption goals WILMINGTON, Del., Oct.
Wilmington, Del., Oct. 3, 2022 - Ashland is introducing Klucel™ xtend hydroxypropyl cellulose (HPC) controlled release matrix former, designed to deliver unsurpassed process versatility and release profile efficiency. It is the latest addition to the company’s Klucel™ product line and further
Ashland announces Klucel™ xtend HPC matrix former for extended-release tablets Wilmington, Del., Oct. 3, 2022 - Ashland is introducing Klucel™ xtend hydroxypropyl cellulose (HPC) controlled release matrix former, designed to deliver unsurpassed process versatility and release profile efficiency.
WILMINGTON, Del., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Effective October 1, 2022, Ashland Inc. (NYSE: ASH) will increase prices up to 15 percent or as contracts allow, to cover continued general inflation related to raw materials, energy, freight, and labor. The price increase includes all Ashland
Wilmington, Del., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Ashland has announced a strategically significant expansion of its Viatel ™ bioresorbable polymer manufacturing and research and development site at the National Science Park, home to a network of innovative organizations, in Mullingar, Ireland.
Ashland proceeds will fund environmental trust WILMINGTON, Del., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Ashland, Inc. (NYSE: ASH) today announced it has completed the sale of approximately six acres of land located in Ajax, Canada to Sunray Group of Hotels Inc., a leading real estate developer with a